The role of maternal serum and breast milk adipokines in determining postpartum and infant adiposity development by Mohamad, Marhazlina
THE ROLE OF MATERNAL SERUM AND    
BREAST MILK ADIPOKINES IN DETERMINING 
POSTPARTUM AND INFANT ADIPOSITY 
DEVELOPMENT 
 
 
 
 
 
 
MARHAZLINA BINTI MOHAMAD 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
 
2016 
THE ROLE OF MATERNAL SERUM AND    
BREAST MILK ADIPOKINES IN DETERMINING 
POSTPARTUM AND INFANT ADIPOSITY 
DEVELOPMENT 
 
 
 
 
by 
 
 
MARHAZLINA BINTI MOHAMAD 
 
 
 
Thesis submitted in fulfillment of the requirements            
for the degree of                                                         
Doctor of Philosophy 
 
 
September 2016 
ii 
 
ACKNOWLEDGEMENTS 
 
I would like to express my deepest gratitude to my supervisor Associate Professor Dr. Hamid 
Jan bin Jan Mohamed for accepting me as his student, and particularly for his continuous 
guidance and support towards the completion of this thesis. It has never been an easy path 
for me to get to this point. I am greatly indebted to him for all his help and kindness. I would 
also like to offer my appreciation to my co-supervisor Dr. Soo Kah Leng for her intellectual 
contributions and encouragement, thus helping me to fulfil my goal to finish this study. 
 
 I would like to thank Kementerian Pengajian Tinggi Malaysia and Universiti Sultan 
Zainal Abidin (UniSZA) for funding my doctorate study under SLAI scheme. I would also 
like to thank Universiti Sains Malaysia (USM) for the financial support in my research 
project through the Research University Grant (1001/PPSK/811087). 
 
My sincere gratitude goes to all pregnant mothers for their willingness to participate 
in my study and for their continuous cooperation. Without these kind-hearted mothers, this 
thesis might not have been possible to exist. Many thanks to the hospital and clinic staff for 
their cooperation and help throughout this study. I am also grateful to Dr. Lim Poh Ying, 
who has been so kind and helpful in providing me guidance and advice on statistical 
analysis. I would like to acknowledge all of the additional support that I had received from 
the staff of Nutrition Programme, Central Research Lab and Science Lab Management Unit. 
 
 Finally, my heartfelt gratitude to my beloved parents (Mohamad bin Daud and 
Limah binti Jusoh) and siblings (Marshaliza, Marzila Azira, Mafashurina, Haizaam Rozaam 
and Marshahidatul Shahirah) for their enormous love, care, patience and support, as well as 
to my dearest friends (Dr. Loy See Ling, Dr. Chen Seong Ting and Pn. Asaritaminaziah 
Hisam) for their generous help, encouragement and support throughout my doctorate study.  
iii 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENT S ..................................................................................................... ii 
TABLE OF CONTENTS ........................................................................................................ iii 
LIST OF TABLES ................................................................................................................ viii 
LIST OF FIGURES ................................................................................................................. x 
ABSTRAK ............................................................................................................................ xiv 
ABSTRACT .......................................................................................................................... xvi 
CHAPTER 1: INTRODUCTION ............................................................................................ 1 
1.1      Background ............................................................................................................ 1 
1.2      Rationales ............................................................................................................... 5 
1.3      Objectives ............................................................................................................... 6        
1.3.1       General objective ......................................................................................... 6 
1.3.2       Specific objectives ....................................................................................... 6 
1.4      Research questions ................................................................................................. 7 
1.5      Alternative hypotheses ........................................................................................... 8 
1.6      Significance of study .............................................................................................. 8 
1.7      Conceptual framework ........................................................................................... 9 
1.8      Operational definitions ......................................................................................... 11 
CHAPTER 2: LITERATURE REVIEW ............................................................................... 13 
2.1 Obesity ................................................................................................................. 13 
2.2 Prevalence of obesity ........................................................................................... 14 
2.3 Dietary intake during pregnancy and obesity ...................................................... 15 
2.4 Obesity in pregnancy and implications ................................................................ 18 
2.5 Obesity and adipokines ........................................................................................ 19 
2.5.1 Adiponectin ............................................................................................... 20 
 2.5.1 (a) Adiponectin in pregnancy .................................................................. 26 
 2.5.1 (b) Adiponectin in breast milk ................................................................. 27 
iv 
 
 2.5.1 (c) Association of maternal serum and breast milk adiponectin levels ... 28 
 2.5.2 Leptin ......................................................................................................... 29 
 2.5.2 (a) Leptin in pregnancy ........................................................................... 30 
2.6 Postpartum weight retention (PPWR) and associated risk factors ....................... 31 
2.6.1 Maternal serum adipokines and postpartum weight retention (PPWR) ..... 34 
2.6.2 Prenatal factors associated with postpartum weight retention (PPWR) .... 35 
2.7 Associated factors of adiposity development in childhood .................................. 37 
2.7.1 Indicators of infant adiposity ..................................................................... 37 
2.7.2 Prenatal serum adipokines and infant adiposity ........................................ 38 
2.7.3 Milk adiponectin and infant adiposity ....................................................... 39 
2.7.4 Maternal factors associated with infant adiposity ...................................... 40 
CHAPTER 3: MATERIALS AND METHODS ................................................................... 42 
3.1 Study sample and setting ..................................................................................... 42 
3.2 Study design ......................................................................................................... 43 
3.3 Sample size .......................................................................................................... 45 
3.4 Sampling method ................................................................................................. 47 
3.5 Data collection ..................................................................................................... 49 
3.5.1 Structured questionnaire ............................................................................ 49 
3.5.2 Anthropometric measurements .................................................................. 49 
3.5.2 (a) Maternal height .................................................................................. 50 
3.5.2 (b) Maternal weight ................................................................................. 50 
3.5.2 (c) Maternal body mass index (BMI) ...................................................... 51 
3.5.2 (d) Maternal total body fat, muscle mass and visceral fat rating ............. 52 
3.5.2 (e) Maternal gestational weight gain (GWG) .......................................... 53 
3.5.2 (f) Maternal fat mass gain ....................................................................... 54 
3.5.2 (g) Maternal muscle mass gain ................................................................ 54 
3.5.2 (h) Maternal visceral fat rating gain ........................................................ 55 
3.5.2 (i) Postpartum weight retention (PPWR) ................................................ 55 
v 
 
3.5.2 (j) Maternal body circumferences ........................................................... 55 
3.5.2 (k) Infant length ....................................................................................... 56 
3.5.2 (l) Infant weight ...................................................................................... 56 
3.5.2 (m) Infant body circumferences ................................................................ 56 
3.5.2 (n) Infant skinfold thicknesses ................................................................. 58 
3.5.2 (o) Infant growth indices ......................................................................... 58 
3.5.3 Dietary assessment..................................................................................... 59 
3.5.3 (a) Maternal 24-hour diet recalls (DR) .................................................... 59 
3.5.3 (b) Infant feeding ..................................................................................... 60 
3.5.4 Maternal physical activity assessment ....................................................... 61 
3.5.5 Maternal physical discomforts ................................................................... 62 
3.5.6 Blood pressure measurement ..................................................................... 63 
3.5.7 Clinical biochemistry sample collection .................................................... 63 
3.6 Principles and procedures of clinical biochemistry analyses ............................... 64 
3.6.1 Analysis for blood glucose ........................................................................ 64 
3.6.2 Analysis for total cholesterol (TC) ............................................................ 65 
3.6.3 Analysis for triglycerides (TG) .................................................................. 66 
3.6.4 Analysis for high density lipoprotein cholesterol (HDL-C) ...................... 67 
3.6.5 Estimation for low density lipoprotein cholesterol (LDL-C) .................... 68 
3.6.6 Analysis for serum adiponectin ................................................................. 69 
3.6.7 Analysis for breast milk adiponectin ......................................................... 71 
3.6.8 Analysis for serum leptin ........................................................................... 72 
3.7 Statistical analysis ................................................................................................ 75 
CHAPTER 4: RESULTS  ...................................................................................................... 79 
4.1 Maternal characteristics ....................................................................................... 79 
4.2 Maternal anthropometry ....................................................................................... 80 
4.3 Maternal dietary intake ........................................................................................ 82 
4.4 Maternal physical activity .................................................................................... 84 
vi 
 
4.5 Maternal physical discomforts ............................................................................. 85 
4.6 Maternal clinical biochemistry profile and blood pressure .................................. 88 
4.7 Maternal adipokines levels .................................................................................. 89 
4.8 Associations of serum adiponectin with breast milk adiponectin ........................ 90 
4.9 Postpartum anthropometry ................................................................................... 92 
4.10 Postpartum lifestyle characteristics ...................................................................... 95 
4.11 Associations of prenatal factors with PPWR ....................................................... 97 
4.12 Infants characteristics, care and breastfeeding patterns ....................................... 99 
4.13 Infants nutritional status ..................................................................................... 100 
4.14 Associations  of  serum  and  breast  milk  adipokines  levels  with  infants      
adiposity ............................................................................................................. 102 
CHAPTER 5: DISCUSSION ............................................................................................... 109 
5.1 Maternal nutritional status, dietary intake, physical activity, physical 
discomforts, lipid profiles and serum adiponectin and leptin levels during 
pregnancy ........................................................................................................... 109 
5.1.1 Maternal nutritional status ....................................................................... 109 
5.1.2 Maternal dietary intake ............................................................................ 111 
5.1.3 Maternal physical activity ........................................................................ 112 
5.1.4 Maternal physical discomforts ................................................................. 113 
5.1.5 Maternal lipid profiles ............................................................................. 114 
5.1.6 Maternal serum adiponectin and leptin levels ......................................... 116 
5.2 Effects of maternal serum adiponectin levels during pregnancy on maternal 
breast milk adiponectin levels ............................................................................ 118 
5.2.1 Maternal breast milk adiponectin levels .................................................. 118 
5.2.2 Association of maternal serum adiponectin levels during pregnancy 
with breast milk adiponectin levels ......................................................... 119 
5.3 Effects of prenatal factors and maternal serum adiponectin and leptin levels 
during pregnancy on 12 months PPWR ............................................................. 120 
5.3.1 Postpartum weight retention (PPWR)...................................................... 121 
5.3.2 Associations of prenatal factors and maternal serum adiponectin and 
leptin levels during pregnancy with 12 months PPWR ........................... 122 
vii 
 
5.4 Effects of maternal serum adiponectin and leptin levels during pregnancy and 
breast milk adiponectin levels on infant adiposity development during the 
first year of life ................................................................................................... 124 
5.4.1 Infants nutritional status and breastfeeding pattern during the first year 
of life ........................................................................................................ 124 
5.4.2 Associations of maternal serum adiponectin and leptin levels during 
pregnancy with infant adiposity development during the first year of 
life ............................................................................................................ 127 
5.4.3 Associations of maternal breast milk adiponectin levels within 2 
months postpartum with infant adiposity development during the first 
year of life ................................................................................................ 129 
5.5 Strengths ............................................................................................................ 133 
5.6 Limitations ......................................................................................................... 135 
5.7 Recommendations .............................................................................................. 136 
CHAPTER 6: CONCLUSION............................................................................................. 138 
REFERENCES .................................................................................................................... 140 
 
APPENDICES  
Appendix A Ethical approval letter from the Human Research Ethics Committee of 
Universiti Sains Malaysia 
Appendix B Ethical approval letter from the Medical Research Ethics Committee of 
Ministry of Health, Malaysia 
Appendix C Written informed consent 
Appendix D Questionnaires 
Appendix E Summary of data and sample collection throughout the study 
 
LIST OF PUBLICATIONS 
 
 
 
 
 
 
viii 
 
LIST OF TABLES 
 
Table 3.1 Calculations of sample size for specific objective (i) and (ii) ...................... 45 
Table 3.2 Calculations of sample size for specific objective (iii), (iv), (v) and (vi) ..... 46 
Table 3.3 WHO classification of BMI ......................................................................... 52 
Table 3.4 Classification of body fat percentage ........................................................... 53 
Table 3.5 Classification of visceral fat rating ............................................................... 53 
Table 3.6 Recommended total gestational weight gain according to prepregnancy   
BMI .............................................................................................................. 54 
Table 3.7 Definitions of growth indicators according to Z-scores ............................... 59 
Table 3.8 Scoring protocol for the continuous score of physical activity .................... 61 
Table 3.9 Scoring protocol for the categorical score of physical activity .................... 62 
Table 4.1 Maternal characteristics at recruitment (n=155) ........................................... 79 
Table 4.2 Maternal anthropometric measurements (n=155) ........................................ 80 
Table 4.3 Maternal energy and macronutrients intake at second and third 
trimesters of pregnancy (n=155) .................................................................. 83 
Table 4.4 Distribution of macronutrients to energy intake at second and third 
trimesters of pregnancy (n=155) .................................................................. 84 
Table 4.5 MET-minutes/week of maternal physical activity at second and third 
trimesters of pregnancy (n=155) ................................................................... 84 
Table 4.6 Maternal physical discomforts throughout pregnancy (n=155) ................... 86 
Table 4.7 Bivariate correlations for total composite score of physical discomforts 
and maternal weight gain rate (WGR) at second and third trimesters of 
pregnancy ..................................................................................................... 87 
Table 4.8 Maternal clinical biochemistry profile and blood pressure .......................... 88 
Table 4.9 Maternal serum and breast milk adipokines at second and third 
trimesters of pregnancy ................................................................................ 90 
Table 4.10 Regression coefficients (p-values) of maternal serum adiponectin levels 
at second and third trimesters of pregnancy on breast milk adiponectin 
level .............................................................................................................. 92 
 
Table 4.11 Anthropometric measurements of the mothers within the first year 
postpartum………….. .................................................................................. 93 
ix 
 
Table 4.12 Total energy intake, physical activity levels and breastfeeding practice 
of the mothers within the first year postpartum ............................................ 96 
Table 4.13 Regression coefficients (p-value) of prenatal factors on the first year 
postpartum weight retention ........................................................................ 98 
Table 4.14 Infants characteristics (n=152) ..................................................................... 99 
Table 4.15 Infants care and breastfeeding pattern in the first year of life .................... 100 
Table 4.16 Infants anthropometric measurements ........................................................ 101 
Table 4.17 Regression coefficients (p-value) of maternal serum and breast milk 
adipokines on infant body weight .............................................................. 103 
Table 4.18 Regression coefficients (p-value) of maternal serum and breast milk 
adipokines on infant body mass index-for-age (BAZ) ............................... 104 
Table 4.19 Regression coefficients (p-value) of maternal serum and breast milk 
adipokines on infant abdominal circumference .......................................... 106 
Table 4.20 Regression coefficients (p-value) of maternal serum and breast milk 
adipokines on infant triceps skinfold .......................................................... 107 
Table 4.21 Regression coefficients (p-value) of maternal serum and breast milk 
adipokines on infant subscapular skinfold-for-age (SSAZ) ....................... 108 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
LIST OF FIGURES 
 
Figure 1.1 Foetal adaptations to undernutrition: a framework......................................... 2 
Figure 1.2 Proposed model of imbalance adipokines level and obesity programming ... 4 
Figure 1.3 Conceptual framework of the study ............................................................. 10 
Figure 2.1 Structure of adiponectin ............................................................................... 20 
Figure 2.2 A disease entity of hypoadiponectinaemia ................................................... 24 
Figure 3.1 Location of the study  .................................................................................. 43 
Figure 3.2 Flow chart of the study ................................................................................. 44 
Figure 3.3 Sampling of the study  .................................................................................. 48 
Figure 3.4 Principle of the sequence enzyme-linked immunosorbent assay (ELISA) .. 69 
Figure 3.5 Principle of the simultaneous enzyme-linked immunosorbent assay 
(ELISA)…………….. .................................................................................. 73 
Figure 4.1 Total gain in gestational weight, fat mass, muscle mass and visceral fat 
rating according to prepregnancy Body Mass Index (n=155) ...................... 81 
Figure 4.2 Status of total gestational weight gain by prepregnancy Body Mass 
Index (n=155) ............................................................................................... 82 
Figure 4.3 Median energy and macronutrients intakes as percentage of 
Recommended Nutrient Intakes (RNI) at second and third trimesters of 
pregnancy (n=155)….  .................................................................................. 83 
Figure 4.4 Maternal physical activity categories at second and third trimesters of 
pregnancy (n=155)….  .................................................................................. 85 
Figure 4.5 Percentage of mothers with hospital admission due to very severe 
pregnancy physical discomforts (n=152) ..................................................... 87 
Figure 4.6 Percentage of mothers with normal and high risk levels of lipid profile 
at second and third trimesters of pregnancy (n=152) ................................... 89 
Figure 4.7 Correlation plot with regression line between maternal serum 
adiponectin levels during pregnancy and breast milk adiponectin level at 
birth…………………  .................................................................................. 91 
Figure 4.8 Correlation plot with regression line between maternal serum 
adiponectin levels during pregnancy and breast milk adiponectin level at 
2 months…………….  .................................................................................. 91 
Figure 4.9 Changes of body weight, Body Mass Index (BMI) and total body fat of 
the mothers during pregnancy until 12 months postpartum ......................... 94 
Figure 4.10 Postpartum weight retention within the first year after birth according to 
prepregnancy Body Mass Index categories .................................................. 95 
Figure 4.11 Physical activity categories during pregnancy until 12 months 
postpartum .................................................................................................... 96 
xi 
 
LIST OF SYMBOLS AND ABBREVIATIONS 
 
Acrp30   Adipocyte complement-related protein of 30 kDa 
AdipoQ   Adiponectin, C1Q and collagen domain containing 
AdipoR1   Adiponectin receptor 1 
AdipoR2   Adiponectin receptor 2 
ANOVA   Analysis of variance 
apM1   Adipose most abundant gene transcript-1 
BAZ   Body mass index-for-age Z-scores 
BMI  Body mass index 
CRP  C-reactive protein 
CV  Coefficients of variability 
DR   Diet recalls 
ELISA  Enzyme-linked immunosorbent assay 
FH  Food hypersensitive 
GBP28  Gelatin-binding protein of 28 kDa 
GDM  Gestational diabetes mellitus 
GOD  Glucose oxidase 
GK  Glucokinase 
GPO  Glycerophosphate oxidase 
GWG  Gestational weight gain 
H2O2  Hydrogen peroxide 
HDL-C  High density lipoprotein cholesterol 
HRP  Horseradish peroxidase 
HSD  Honest significant difference 
HUSM  Hospital Universiti Sains Malaysia 
HMW  High-molecular-weight 
IGF-1  Insulin-like growth factor 1 
xii 
 
IOM  Institute of Medicine 
IPAQ  International Physical Activity Questionnaire 
IPH  Institute for Public Health 
IQR  Interquartile range 
LAZ  Length-for-age Z-scores 
LDL-C  Low density lipoprotein cholesterol 
LGA  Large-for-gestational age 
LMP  Last menstrual period 
LMW  Low-molecular-weight 
MET  Metabolic equivalent task 
MLR  Multiple linear regression 
MUAC  Mid-upper arm circumference 
NASH  Nonalcoholic steatohepatitis 
NCCFN  National Coordinating Committee on Food and Nutrition 
NCEP  National Cholesterol Education Program 
NFH  Non-food hypersensitive 
NHMS  National Health and Morbidity Survey 
O2  Oxygen 
Ox-LDL  Oxidized-low density lipoprotein 
PAP  Phenol aminophenazone 
PBST  Phosphate buffered saline tween-20 
PIH  Pregnancy-induced hypertension 
POD  Peroxidase 
PPWR  Postpartum weight retention 
PSQ  Pregnancy Symptoms Questionnaire 
RNI  Recommended Nutrient Intakes 
SD  Standard deviation 
SGA  Small-for-gestational-age 
xiii 
 
SOB  Shortness of breath 
SPSS  Statistical Package for Social Sciences 
SSAZ  Subscapular skinfold-for-age Z-scores 
TC  Total cholesterol 
TG  Triglycerides 
TMB  Tetramethylbenzidine 
TNF-α  Tumour necrosis factor alpha 
TWG  Total gestational weight gain 
UNSCN  United Nations System Standing Committee on Nutrition 
USDA  U.S. Department of Agriculture 
USM  Universiti Sains Malaysia 
VLDL-C  Very low density lipoprotein cholesterol 
WAZ  Weight-for-age Z-scores 
WLZ  Weight-for-length Z-scores 
WGR  Weight gain rate 
WHO  World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
PERANAN ARAS ADIPOKIN SERUM DAN SUSU IBU DALAM MENENTUKAN 
ADIPOSITI IBU SELEPAS BERSALIN DAN BAYI 
 
ABSTRAK 
 
 Obesiti menjadi kebimbangan di Malaysia berikutan peningkatan prevalen yang 
merisaukan kebelakangan ini. Selain menyimpan lemak, tisu lemak juga merupakan organ 
endokrin yang berfungsi merembes sejumlah besar adipokin. Kehamilan, iaitu keadaan di 
mana terjadinya perubahan metabolik, dikenalpasti sebagai tempoh kritikal bermulanya 
adipositi dalam kalangan ibu dan bayi akibat ketidakseimbangan penghasilan adipokin. 
Justeru, Kajian Kohort Kehamilan Universiti Sains Malaysia telah dijalankan untuk 
mengkaji peranan aras adipokin (adiponektin dan leptin) serum dan susu ibu dalam 
menentukan pengekalan berat badan ibu selepas bersalin (PPWR) dan adipositi bayi dalam 
tempoh setahun pertama kelahiran. Kajian ini dijalankan dari April 2010 hingga Disember 
2012. Seramai 155 ibu hamil yang sihat berusia di antara 19 hingga 40 tahun telah direkrut 
pada trimester pertama dan kedua kehamilan bertempat di negeri Kelantan, Malaysia. 
Pengumpulan data meliputi sosio-demografi, sejarah perubatan, antropometri, pemakanan, 
aktiviti fizikal, ketidakselesaan fizikal dan analisis biokimia klinikal ibu; serta antropometri 
dan pola pemberian makanan bayi. Sampel serum berpuasa diambil semasa tempoh 
kehamilan untuk analisa aras glukosa darah, profil lipid, adiponektin dan leptin. Sampel susu 
ibu diambil sejurus selepas bersalin dan 2 bulan selepas bersalin. Pengumpulan data telah 
dilakukan pada trimester kedua dan ketiga kehamilan, diikuti pengumpulan data susulan 
sejurus selepas bersalin, 2 bulan, 6 bulan dan 12 bulan selepas bersalin. Analisa regresi linear 
berganda (MLR) telah dijalankan untuk mengkaji; 1) perkaitan di antara aras adiponektin 
serum ibu semasa kehamilan dengan aras adiponektin susu ibu dalam tempoh 2 bulan selepas 
bersalin; 2) perkaitan di antara faktor pranatal dan aras adiponektin dan leptin serum ibu 
dengan PPWR 12 bulan selepas bersalin; dan 3) perkaitan di antara aras adiponektin dan 
xv 
 
leptin serum dan susu ibu dengan adipositi bayi. Model MLR menunjukkan aras adiponektin 
susu ibu sejurus selepas bersalin meningkat dengan peningkatan aras adiponektin serum ibu 
pada trimester ketiga (p=0.006), manakala aras adiponektin susu ibu semasa 2 bulan selepas 
bersalin meningkat dengan peningkatan aras adiponektin serum ibu pada trimester kedua dan 
ketiga (p=0.035, p=0.006). Semasa 12 bulan selepas bersalin, PPWR meningkat dengan 
peningkatan kadar penambahan berat badan (WGR) pada trimester ketiga (p<0.001), dan 
menurun dengan peningkatan aras kolesterol HDL pada trimester kedua (p<0.001). Dalam 
tempoh usia setahun pertama, berat badan, skor-Z BMI-untuk-umur, lilitan abdomen dan 
ketebalan tricep bayi menurun dengan peningkatan aras adiponektin serum dan susu ibu 
(p<0.05). Kesimpulannya, 1) aras adiponektin serum ibu semasa kehamilan dikaitkan dengan 
aras adiponektin susu ibu dalam tempoh 2 bulan selepas bersalin; 2) WGR dan aras 
kolesterol HDL semasa kehamilan dikaitkan dengan PPWR 12 bulan selepas bersalin; dan 3) 
aras adiponektin serum dan/atau susu ibu dikaitkan dengan adipositi bayi dalam tempoh 
setahun pertama kelahiran. Dapatan yang memberangsangkan bagi adiponektin susu ibu 
menunjukkan potensi amalan penyusuan susu ibu dalam pencegahan obesiti sejak usia bayi.  
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THE ROLE OF MATERNAL SERUM AND BREAST MILK ADIPOKINES IN 
DETERMINING POSTPARTUM AND INFANT ADIPOSITY DEVELOPMENT 
 
ABSTRACT 
 
 Obesity has been a great concern in Malaysia since there is an alarming increase in 
its prevalence. Besides storing fat, adipose tissue is also an endocrine organ that secretes a 
large number of adipokines. Pregnancy, a state with metabolic changes, has been recognized 
as a critical period for the development of maternal and infant adiposity as a result of 
imbalanced adipokines production. Hence, the Universiti Sains Malaysia Pregnancy Cohort 
Study was established to investigate the role of maternal serum and breast milk adipokines 
(adiponectin and leptin) in determining the first year postpartum weight retention (PPWR) 
and infant adiposity development. This study was conducted from April 2010 until 
December 2012. A total of 155 healthy pregnant mothers aged 19 to 40 years were recruited 
at first and second trimester of pregnancy in Kelantan, Malaysia. Data collection were 
consisted of maternal socio-demography, medical history, anthropometry, dietary, physical 
activity, physical discomforts and clinical biochemistry analysis; and infant’s anthropometry 
and feeding patterns. Fasting serum samples were taken during pregnancy for the serum 
glucose, lipid profile, adiponectin and leptin levels analyses. Breast milk samples were 
collected at birth and 2 months postpartum. Data collection was performed at second and 
third trimester of pregnancy, continued with follow-up visits at birth, 2 months, 6 months 
and 12 months postpartum. Multiple linear regression (MLR) analyses were performed to 
examine; 1) the associations of maternal serum adiponectin with breast milk adiponectin 
within 2 months postpartum; 2) the associations of prenatal factors and maternal serum 
adiponectin and leptin on 12 months PPWR; and 3) the associations of maternal serum and 
breast milk adiponectin and leptin on infant adiposity development. MLR models showed 
that breast milk adiponectin at birth increased with increasing maternal serum adiponectin at 
xvii 
 
third trimester (p=0.006), while breast milk adiponectin at 2 months postpartum increased 
with increasing maternal serum adiponectin at second and third trimesters respectively 
(p=0.035, p=0.006). At 12 months postpartum, PPWR increased with increasing weight gain 
rate (WGR) at third trimester (p<0.001), and decreased with increasing HDL-cholesterol at 
second trimester (p<0.001). In the first year of age, as maternal serum and breast milk 
adiponectin increased, infant weight, BMI-for-age Z-scores, abdominal circumference and 
triceps skinfold significantly decreased (p<0.05). In conclusion, 1) maternal serum 
adiponectin during pregnancy was associated with breast milk adiponectin within 2 months 
postpartum; 2) WGR and HDL-cholesterol during pregnancy were related with 12 months 
PPWR; and 3) maternal serum and/or breast milk adiponectin were associated with the first 
year infant adiposity development. The favourable results of breast milk adiponectin 
indicated the potential role of breastfeeding practice in the prevention of obesity since 
infanthood. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
 
Obesity has become a serious concern due to the sharp increasing rates worldwide. In fact, 
obesity is considered as a root cause for global mortality and disease burden, in which it was 
associated with well-known comorbidities such as cardiovascular disease, type 2 diabetes 
mellitus, hypertension, osteoarthritis, cancers, psychological distress (Basen-Engquist and 
Chang, 2011; Pedersen et al., 2012; Bastien et al., 2014), as well as cognitive impairment 
and risk of dementia in later life (Whitmer et al., 2008). 
 
 Nowadays, obesity among population groups differentiated by gender and age are at 
alarming rate. In 2014, 40% of women worldwide aged 18 years and over were overweight 
compared to 38% of men (WHO, 2015). As reported in NHMS 2015, 20.6% of women in 
Malaysia were obese compared to 15.0% of men (IPH, 2015). In recent years, overweight 
among women in most developing countries was found to exceed the underweight (UNSCN, 
2010). In the meantime, childhood obesity has also shown an escalating rate in which in the 
year of 2013 over 42 million children under the age of 5 were overweight or obese (WHO, 
2015). While the prevalence of overweight/obese among Malaysian school-aged children 
was increased from 20.7% in 2002 to 26.4% in 2008 (Ismail et al., 2009). 
 
  As the current trend of obesity continues, it has become an alarming concern 
particularly among women since obesity increases the risk of obstetric complications (Kulie 
et al., 2011) as well as contributes to high postpartum weight retention (Haugen et al., 2014). 
As a result, maternal distressing condition will subsequently expose their offspring to 
adiposity thus a higher risk of health problems in adulthood (Yu et al., 2006). The 
‘developmental origins of chronic adult disease’ hypothesis proposed by Barker (2004) 
2 
 
(Source: Barker, 1998) 
emphasizes the crucial role of intrauterine environment in the early development and 
subsequent life-long health of the foetus. The hypothesis states that the adverse prenatal 
environment may influence the physiology and metabolism of the foetus, thus results to 
‘programming’ described as the condition in which the foetus changes the body’s structure, 
function and metabolism as a way to adapt to the scarce environment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Foetal adaptations to undernutrition: a framework 
 
Figure 1.1 shows the foetal programming as proposed by Barker (1998). In limited supply of 
nutrients foetus responds to adverse intrauterine environment by altering metabolic processes 
and synthesis of growth factors as well as redistributing blood flow, which eventually result 
to disproportionate growth of foetus. Based on this hypothesis and the present trend of 
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obesity, the classic view that the adulthood diseases are associated with adult lifestyles and 
genetic factors has been projected to another important factor that plays a vital role to the 
underlying cause of the health problems. The wider parameters and better understanding of 
the mechanisms would probably provide more comprehensive and effective prevention 
programmes of obesity in the future. 
 
Defining as the consequence of an energy imbalance, obesity is associated with 
myriad interrelated factors that increase the positive energy balance such as dietary intake, 
physical activity level, environmental, societal, cultural, psychological, genetic, non-genetic 
biological susceptibility and medical (WHO, 2000; Rankinen et al., 2006; Lopez, 2007). The 
complex and multi-factorial interactions in a long term would subsequently lead to weight 
gain, or particularly the increment of adipose tissues. Given that the role of adipose tissue as 
an endocrine organ, the changes of the volume and number of adipocytes due to obesity may 
result to the changes in endocrine and metabolic functions of adipose tissue including the 
secretion of adipokines (Weisberg et al., 2003). 
 
Adipokines are a number of adipocyte-derived secretory factors, which are 
responsible for the regulation of multiple metabolic pathways (Badman and Flier, 2007). 
Adiponectin and leptin are among the most potent and most studied adipokines in relations 
to obesity. As a major circulating protein in blood, adiponectin modulates glucose and fatty 
acid metabolism (Chandran et al., 2003), and was associated with insulin sensitivity 
(Tschritter et al., 2003). Two distinct human adiponectin receptors were abundantly 
expressed in skeletal muscle, heart, kidney and lung (AdipoR1) as well as in the liver 
(AdipoR2) (Yamauchi et al., 2003; Zhou et al., 2005). Given that AdipoR1 is also expressed 
in small intestine of neonatal mouse (Zhou et al., 2005), it is possible that oral adiponectin 
particularly lactation has direct role in infants. The presence of adiponectin in human breast 
milk suggests its protective effects on infants (Martin et al., 2006). On the other hand, serum 
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leptin plays a vital role in energy balance regulation and acts in the hypothalamus to supress 
appetite and increase energy expenditure (Stocker and Cawthorne, 2008). Yet, the functional 
role of serum and breast milk adiponectin and leptin on maternal and childhood obesity 
among local mothers and infants remain uncertain, thus warrants further investigations.  
 
Proposed model of intrauterine imbalance of adipokines level based on foetal 
programming hypothesis was presented in Figure 1.2. The imbalance maternal adipokines 
level in the intrauterine may induce the foetal programming, wherein it may permanently 
change the foetal metabolism and appetite regulation. Consequently, it may lead to the 
childhood obesity and the development of health problems in later life. Knowing that obesity 
is a difficult to reverse condition and the treatment result is often frustrating, the strategy of 
early prevention particularly at the intrauterine stage is critically needed in order to stop the 
intergenerational cycle of obesity.  
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Proposed model of imbalance adipokines level and obesity programming 
 
 
Imbalance adipokines level 
     
 
 
Maternal obesity 
     
 
     
Childhood obesity 
     
Adulthood obesity and 
health problems 
 
     
Foetal programming 
 
5 
 
1.2 Rationales 
 
The steep increase of obesity among women and the subsequent effects of maternal adiposity 
on the offspring health demand an urgent attention to elucidate the significant factors that 
contribute to obesity. The retention of gestational weight gain is one of the potential way of 
developing obesity among childbearing age women (Siega-Riz et al., 2004) and the offspring 
who exposed to maternal adiposity are at higher risk of being obese and developing 
metabolic syndromes in later life (Hochner et al., 2012; O'Reilly and Reynolds, 2013). In the 
meantime, pregnancy is the condition in which profound physiological and endocrinological 
alterations take place to meet the increased demands of maternal body and growing foetus, as 
well as to prepare the mothers for parturition and lactation (Picciano, 2003; Carlin and 
Alfirevic, 2008). It is of great interest to investigate the relationship of maternal and infant 
adiposity with adiponectin and leptin, which were known to play a major role in energy 
metabolism and weight control (Meier and Gressner, 2004; Qi et al., 2004).  
 
 As a number of international studies reported the association of serum adiponectin 
and leptin during gestation and breast milk adiponectin with postpartum and infant adiposity 
(Stein et al., 1998; Woo et al., 2009; Wang et al., 2010; Josefson et al., 2013; Kew et al., 
2014), however in Malaysia there is a dearth of scientific data regarding that. This limitation 
demonstrates the need for comprehensive longitudinal study targeting mothers and infants, in 
order to obtain the greater insight of the factors that make up the whole obesity issue in both 
populations in Malaysia.  
 
In light of that, it is hoped that this study would provide meaningful information on 
the contribution of maternal serum adipokines, breast milk adiponectin and other prenatal 
factors to the postpartum weight retention (PPWR) and the development of infant adiposity, 
particularly among Malay mothers and children. A better understanding of the characteristics 
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related to the pathogenesis of obesity would be a strong foundation in formulating and 
implementing the effective and successful obesity prevention programs.  
 
Furthermore, the breastfeeding rates in Malaysia drop rapidly after two or three 
months after delivery, which is when the maternity leave ends and working mothers return to 
work (MOH, 2009). In addition to the breastfeeding campaigns organized by government 
and non-government institutions (e.g. Baby-friendly Hospital Initiative, Mother’s Smart 
Choice Programme, MyNutriBaby etc), it is hoped that the expanding of breast milk 
adiponectin potential role in the prevention of childhood obesity from this study, may also 
provide an avenue towards the development of obesity prevention strategies through the 
practice of breastfeeding.    
 
1.3 Objectives 
 
1.3.1 General objective 
 
To investigate the associations of maternal serum and breast milk adipokines with 
postpartum weight retention (PPWR) and infant adiposity development. 
 
1.3.2 Specific objectives 
 
i. To assess the maternal nutritional status, dietary intake, physical activity, physical 
discomforts, lipid profiles and serum adiponectin and leptin levels during pregnancy. 
ii. To assess the maternal breast milk adiponectin levels within 2 months postpartum. 
iii. To investigate the associations of maternal serum adiponectin levels during 
pregnancy with maternal breast milk adiponectin levels within 2 months postpartum. 
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iv. To investigate the associations of prenatal factors and maternal serum adiponectin 
and leptin levels during pregnancy with 12 months PPWR. 
v. To investigate the associations of maternal serum adiponectin and leptin levels 
during pregnancy with infant adiposity development during the first year of life. 
vi. To investigate the associations of maternal breast milk adiponectin levels within 2 
months postpartum with infant adiposity development during the first year of life. 
 
1.4 Research questions 
 
i. What are the maternal nutritional status, dietary intake, physical activity, physical 
discomforts, lipid profiles and serum adiponectin and leptin levels during 
pregnancy? 
ii. What are the maternal breast milk adiponectin levels within 2 months postpartum? 
iii. Is there any association of maternal serum adiponectin levels during pregnancy with 
maternal breast milk adiponectin levels within 2 months postpartum, after 
controlling the confounders? 
iv. Is there any association of prenatal factors and maternal serum adiponectin and 
leptin levels during pregnancy with 12 months PPWR, after controlling the 
confounders? 
v. Is there any association of maternal serum adiponectin and leptin levels during 
pregnancy with infant adiposity development during the first year of life, after 
controlling the confounders? 
vi. Is there any association of maternal breast milk adiponectin levels within 2 months 
postpartum with infant adiposity development during the first year of life, after 
controlling the confounders? 
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1.5 Alternative hypotheses 
 
i. Hα: Maternal serum adiponectin levels during pregnancy are significantly associated 
with maternal breast milk adiponectin levels within 2 months postpartum. 
ii. Hα: Prenatal factors and maternal serum adiponectin and leptin levels during 
pregnancy are significantly associated with 12 months PPWR. 
iii. Hα: Maternal serum adiponectin and leptin levels during pregnancy are significantly 
associated with infant adiposity development during the first year of life. 
iv. Hα: Maternal breast milk adiponectin levels within 2 months postpartum are 
significantly associated with infant adiposity development during the first year of 
life. 
 
1.6 Significance of study 
 
This pregnancy cohort study was comprised of measurements of diverse parameters among 
mothers and infants throughout gestational period until the first year postpartum. Nutritional 
status, lifestyle indicators such as dietary intake and physical activity as well as blood and 
breast milk analysis were among the main studied variables that were incorporated into the 
study. Therefore, it is hoped that all those information would provide crucial longitudinal 
baseline data on the maternal-infant obesity particularly via the intrauterine interaction, 
provided that it would elucidate the important prenatal factors that contributed to obesity. 
Essentially, these data could somewhat benefit other researchers for better comprehension, 
wider perspective and further investigation in the existing or new studies of obesity. 
 
In spite of various obesity awareness campaigns targeting women were held in 
Malaysia either at the national, state or community levels, unfortunately so far they have had 
no visible effect on reducing women obesity rates. Hence, hopefully the data on obesity 
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development among pregnant mothers obtained from this study would enable the 
improvement of maternal and infant healthcare, particularly in the prevention and treatment 
of obesity. Thus, it would help to the successful implementation of community prevention 
programs or clinical therapies for obesity in future. In addition, the data also support the 
protective effect of breastfeeding practice against obesity, thus it appears that promoting 
breastfeeding is one of important parts of this study.  
 
1.7 Conceptual framework 
 
Figure 1.3 shows the conceptual framework as the background of the study. The imbalance 
in prenatal environment that includes maternal prepregnancy adiposity, poor dietary intake, 
low physical activity level, greater physical discomforts and hyperlipidaemia as well as rapid 
gestational weight gain rate may relate with the concentrations of maternal serum adipokines 
(adiponectin and leptin) during pregnancy and subsequently are responsible for the maternal 
breast milk adiponectin levels.  
 
 On the other hand, the duration of breastfeeding as one of the factors in early 
postnatal environment may also associate with the levels of adiponectin in breast milk. 
Given the importance of adipokines in human physiological and metabolic processes such as 
fatty acid metabolism and energy balance, the impaired levels of maternal serum adipokines 
(adiponectin and leptin) during pregnancy as well as breast milk adiponectin are somewhat 
considered as among the factors that influence the postpartum adiposity and infant adiposity 
development in later life. 
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Figure 1.3     Conceptual framework of the study
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1.8 Operational definitions 
 
Adipokines – proteins that are secreted from (and synthesised by) adipocytes (include 
adiponectin and leptin). 
 
At birth – a follow-up visit, within (median=3, IQR=1-4) days after delivery; for the milk 
collection, within (median=3, IQR=1-5) days after delivery. 
 
Caesarean delivery – a delivery by a surgical procedure, in which one or more incisions are 
made through mother's abdomen and uterus. 
 
Complementary food – food other than breast milk and infant formula given to the child to 
provide nutrients. 
 
Excess weight (prepregnancy BMI category) – mothers with overweight and obese 
prepregnancy BMI status. 
 
Gestational age – a measure of the age of a pregnancy in weeks, from the first day of the 
mother's last menstrual cycle to the current date. 
 
Gravidity – the number of pregnancy, including miscarriage and term delivery. 
 
Healthy pregnancy – a pregnancy in the absence of pre-existing or currently diagnosed 
chronic medical condition and pregnancy complications.  
 
High birth weight (HBW) – birth weight of more than 4000g. 
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Low birth weight (LBW) – birth weight of less than 2500g. 
 
Normal delivery – a delivery through the vagina. 
 
Parity – the number of >20 weeks birth, including stillborn. 
 
Postpartum/ postnatal period – a period after delivery or birth (postpartum is the term used 
for the mothers, while postnatal is the term used for the infants). 
 
Prenatal factors – include maternal nutritional status, dietary intake, physical activity, 
physical discomforts and lipid profiles. 
 
Prenatal period – a period during pregnancy before delivery or birth. 
 
Term delivery – a delivery between 37 and 42 weeks of gestation. 
 
Trimesters of pregnancy – comprised of three stages of pregnancy period; the first 
trimester (0-13 weeks of gestation), second trimester (14-26 weeks of gestation) and third 
trimester (week 27 to the end of gestation) (APA, 2015). 
 
Visceral fat rating – amount of visceral fat (fat in the abdominal cavity surrounding the 
vital organs), in which visceral fat rating for optimal health should stay under 13.  
 
Weaning age – the age at which the child is firstly introduced to complementary food. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Obesity 
 
In adults, obesity refers to adipocyte hypertrophy (Kadowaki and Yamauchi, 2005), in which 
the enlargement of adipocyte size is predominant in adipose tissue cellularity (Hirsch and 
Batchelor, 1976; Van Harmelen et al., 2003). The imbalance of energy intake and energy 
expenditure often results to adipocyte hypertrophy (Bays et al., 2008). When energy 
consumed exceeds energy expended in prolonged period, it results to the impairment of 
adipogenesis or adipocyte hyperplasia, defined as the failure of adipose organ to recruit and 
proliferate new adipocytes from preadipocytes (Dubois et al., 2006). Consequently, 
individuals with distortion in fat proliferation and differentiation are susceptible to adipocyte 
hypertrophy (Heilbronn et al., 2004). When fat is predominantly deposited through 
hypertrophy and the large adipocyte reaches its limit expansion, human body is exposed to 
adipocyte dysfunction (Rutkowski et al., 2015) and escalated ectopic fat storage (Heilbronn 
et al., 2004; Dubois et al., 2006).  
 
 It was revealed that dietary intake and physical activity level play significant role in 
the development of obesity (Stubbs and Lee, 2004). Higher intake of dietary fat that does not 
match the rate of fat oxidation would subsequently lead to fat imbalance or obesity. While 
along with the composition of fatty acids in the diet, physical activity is also known as one of 
the most effective ways to reduce the transient delay in adaptation to high fat diet (Krishnan 
and Cooper, 2014). Other than the frequently studied poor diet and sedentary lifestyle 
factors, there is a wide range of factors or combination of risk factors that are related to 
obesity. Aging factor was associated with the incidence of obesity regarding the declining 
function of adipose tissue, in which the proliferation and lipolysis were increased among 
younger person, whereas the tendency of lipid accumulation in nonadipose tissue was 
increased among older individual (Schipper et al., 2008). It was also revealed that there is 
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strong link of genetic factor with obesity (Ramachandrappa and Farooqi, 2011), in which the 
inter-individual genetic variations and mutations determine the susceptibility or resistance to 
develop obesity. Other than biological and genetic, psychological factor of depression was 
also associated with obesity through changes in behaviour as it intervenes the behaviour of 
eating and engaging in physical activities (Blaine, 2008).  
 
On the other hand, built environment or obesogenic environment which involves 
human-made factors such as income, density of population and employment, food safety and 
fast food availability has created a vulnerable environment to the risk of developing obesity 
(Lopez, 2007). While among potential risk factors that were recognized to associate with 
childhood obesity are including birth weight, catch-up growth, weight gain within the first 
year of age, adiposity development at early age, parental obesity, television viewing and 
sleep duration (Reilly et al., 2005). 
 
2.2 Prevalence of obesity 
 
Globally, almost 2 billion adults aged 18 years and above were overweight, with more than 
600 million were obese in 2014 (WHO, 2015). Global prevalence of obesity in 2014 was 
more than doubled the prevalence in 1980 (WHO, 2015). Considering the escalating trends 
of obesity continue, it was estimated that up to 3.3 billion of the world’s adult population 
could be overweight by 2030 (Kelly et al., 2008). In Malaysia, the national prevalence of 
overweight has raised from 16.6% in 1996 to 29.1% in 2006, while the national prevalence 
of obesity has escalated from 4.4% in 1996 to 14.0% in 2006, as reported in the Third 
National Health and Morbidity Survey (NHMS III) (Nor et al., 2008). Recently from NHMS 
2015, it was reported that the national prevalence of overweight continued to increase to 
30.0%, while national obesity prevalence of 17.7% has shown four-time increase from the 
level in 1996 (IPH, 2015).  
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The prevalence of women obesity has increased and higher than that of men from 
1980 to 2008, as reported in 16 of 21 regions (Stevens et al., 2012). In fact, it was observed 
that between 1980 and 2008, women BMI had increased by 0.5 kg/m2 per decade worldwide 
(Finucane et al., 2011). While in 2014, 15.0% of women worldwide were obese compared to 
11.0% of men (WHO, 2015). Rapid rising trend of obesity was linked to nutrition transition 
particularly in the developing countries and Asia region (Baker and Friel, 2014). In most 
low-income and middle-income regions, women were observed to have higher BMI than 
men (Finucane et al., 2011). According to the report of NHMS 2015, the prevalence of 
women obesity (20.6%) and abdominal obesity (35.4%) in Malaysia were higher than that of 
men (15.0% and 11.8%, respectively) (IPH, 2015). Compared to NHMS 2006, women 
obesity (17.4%) and abdominal obesity (26.0%) prevalence were also significantly greater 
than that of men (10.0% and 7.3%, respectively) (Nor et al., 2008). 
 
The trend of childhood obesity is soaring upward, wherein by the year 2020 it was 
estimated that the global prevalence of overweight and obesity in children aged 0-5 years 
could reach 9.1% (De Onis et al., 2010). The projection of this trend was based on the 
relative increase of worldwide childhood obesity prevalence from 4.2% in 1990 to 6.7% in 
2010 (De Onis et al., 2010). According to the Nutrition Survey of Malaysian Children in 
2011-2012 among children aged 6 months to 12 years old, it was reported that the prevalence 
of overweight and obese were 9.8% and 11.8%, respectively (Poh et al., 2013). While the 
national prevalence of overweight in children aged less than 5 years from NHMS 2015 has 
reported an increase to 7.6% (IPH, 2015), as compared to the prevalence of 6.4% from 
NHMS 2006 (Khor et al., 2009). 
 
2.3 Dietary intake during pregnancy and obesity 
 
According to the ‘developmental origins of chronic adult disease’ hypothesis, Barker (2004) 
proposed that intrauterine environment is responsible for the changes in foetal body’s 
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structure, physiological and metabolic regulation. Given that intrauterine is a critical period 
of when the cells divide rapidly, hence any exposure to stimulus or insult may trigger foetal 
adaptation by permanently altering the physiology and metabolism that later may predispose 
the infant to chronic diseases (De Boo and Harding, 2006). As a stimulus to the intrauterine 
environment, it was proposed that foetal overnutrition or over supply of energy in prenatal 
period is associated with the childhood and adulthood obesity (McMillen et al., 2009; Desai 
and Ross, 2011). Foetal overnutrition is mostly attributable to maternal adiposity particularly 
of greater prepregnancy weight status and gestational weight gain, in which it may result to 
permanent changes in the function of neuroendocrine, appetite control and energy 
metabolism of the foetus (Armitage et al., 2008). 
 
During pregnancy, the quantity and quality of dietary intake are very important for 
both mothers and infants (Guelinckx et al., 2008). Nutrient intake during the first trimester of 
pregnancy would benefit the process of cells differentiation and the development of organs, 
while in later gestation the nutrients are mostly required for the rapid growth of the foetus 
(Godfrey and Barker, 2001; Burton et al., 2002). The changes in dietary intake during this 
critical period may greatly influence maternal physiological and nutritional metabolism 
(King, 2000).  
 
Excessive and imbalance food intake may pose a greater risk to excess maternal 
weight gain throughout pregnancy as reported in previous studies (Lagiou et al., 2004; 
Olafsdottir et al., 2006; Gardner et al., 2011). A prospective cohort study among multi-
ethnic mothers in the Netherlands showed that there were 1.13-4.49 times higher risk of 
gaining excess gestational weight among those with higher consumption of total energy, 
carbohydrate, protein and fat during pregnancy (Gaillard et al., 2013). The same study also 
reported that excessive gestational weight gain was associated with 1.51 times greater risk of 
childhood overweight as compared to the groups of mothers with recommended and less 
than the recommended gestational weight gain. 
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In terms of quality of food intake, an adjusted multivariate regression model from a 
study among pregnant mothers reported that fried food and dairy intake were the predictors 
for excessive gestational weight gain (Stuebe et al., 2009). While an animal study 
demonstrated that rats fed with junk food diet high in fat, sugar and salt during gestation and 
lactation were more likely to have offspring with escalated adiposity until adulthood (10 
week postpartum) (Bayol et al., 2008). In addition, a prospective cohort study of Project 
Viva in eastern Massachusetts, USA showed that the higher maternal consumption of 
omega-3 polyunsaturated fatty acids (PUFAs) during pregnancy was associated with lower 
childhood adiposity at 3 years of age (Donahue et al., 2011).   
 
On the other hand, it was also revealed that the quality of dietary intake during 
pregnancy was attributed to the prepregnancy weight status. A study showed that fibre and 
folate intake during pregnancy were decreased with the increased of prepregnancy BMI 
(Laraia et al., 2007). In another study, obese pregnant mothers were reported to have lower 
score for diet quality, in which their meal pattern and intake of fruits and vegetables were 
unlikely to meet the recommendation (Derbyshire et al., 2006). While a dietary pattern study 
demonstrated that mothers with greater prepregnancy BMI were prone to the Western diet 
which is of high-fat dairy, processed and red meats, rather than the Healthy and Intermediate 
diet (Knudsen et al., 2008). 
 
Fruits and vegetables intake are of high interest and greatly recommended in diet as 
it poses a protective effect on chronic diseases (Boeing et al., 2012; Slavin and Lloyd, 2012). 
In pregnancy, maternal consumption of fruits and vegetables was significantly associated 
with birth size (Rao et al., 2001; Loy et al., 2011) and glucose tolerance of infants (Yajnik, 
2004). In addition, a study revealed that overweight mothers with suboptimal weight gain 
during gestation had increased fibre intake at late pregnancy, which was contrary to 
overweight mothers with excess weight gain who were reported to decrease the intake of 
fibre in advancing gestation (Olafsdottir et al., 2006). In spite of its benefits, the intake of 
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fruits and vegetables was shown to less likely to meet recommended amount of consumption 
during pregnancy, with only a small percentage of mothers reported to consume enough 
portion per day (Bang and Lee, 2009; Wen et al., 2010; Cooper et al., 2012).  
 
2.4 Obesity in pregnancy and implications 
 
Both maternal prepregnancy weight status and gestational weight gain is closely related to 
adverse effects on mothers and birth outcomes. Mothers with excess weight were prone to 
experience pregnancy health complications such as gestational diabetes (GDM), pregnancy-
induced hypertension and preeclampsia (Rode et al., 2005; Abenhaim et al., 2007; Poston et 
al., 2011). Overweight mothers with GDM were revealed to have higher risk to develop type 
2 diabetes within years of postpartum (Bellamy et al., 2009). On top of that, the risk to 
induced labour and caesarean delivery were increased among overweight mothers during 
labour (Doherty et al., 2006). Previous studies also reported that overweight mothers had 
higher chance to miscarriage (Lashen et al., 2004) and postpartum haemorrhage (Liu et al., 
2011; Fyfe et al., 2012) as compared to mothers with normal BMI. 
 
Obesity in pregnancy was associated with deleterious effects on pregnancy outcomes 
in a way it may increase the risk of health complications to the infant. Maternal obesity was 
demonstrated as a risk factor for infant mortality (Aune et al., 2014) and preterm birth 
(Madan et al., 2010), including induced preterm birth (McDonald et al., 2010). Significant 
link between congenital malformations with overweight mothers was reported in previous 
studies, involving a wide range of birth defect categories (Blomberg and Källén, 2010; 
Gilboa et al., 2010). The incidence of neural tube defects was related with maternal obesity 
(Waller et al., 2007; Agopian et al., 2013) even after supplementation of folic acid (Ray et 
al., 2005). In addition, excess weight in mothers was also shown to influence infant 
overgrowth which particularly result to large-for-gestational age (LGA) and macrosomic 
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newborns (Athukorala et al., 2010; Kerrigan and Kingdon, 2010), as well as increased birth 
weight (Surkan et al., 2004).  
 
Other than that, maternal obesity may affect the health and nutritional status of 
infants during their childhood, such as the development of adiposity (Crozier et al., 2010), 
cognitive function (Smith et al., 2011), blood pressure (Gaillard et al., 2014) and atopic 
diseases (Mihrshahi et al., 2003). In long-term effect, the development of obesity in 
childhood was associated with adulthood obesity and higher risk of developing metabolic 
syndrome (Catalano and Ehrenberg, 2006). A birth cohort study revealed that the greater 
BMI, waist circumference and other cardiometabolic risk factors among young adults at 32 
years later were associated with higher maternal prepregnancy weight and gestational weight 
gain (Hochner et al., 2012). 
 
2.5 Obesity and adipokines 
 
Apart from being the fat storage depot and energy source, the adipose tissue was also 
recognized as an endocrine organ which secretes a large number of cytokines and hormones 
(adipokines) (Galic et al., 2010). Adipokines refer to bioactive proteins that are synthesised 
by or expressed from adipocytes (Trayhurn and Wood, 2004). As adipokines were known to 
play critical roles in lipid and glucose metabolism (Hauner, 2005; Matsuzawa, 2006; Halberg 
et al., 2008), therefore individuals with distorted function of adipocytes would experience 
severe alterations in adipokines secretion and are thus highly predisposed to the development 
of metabolic syndrome and other adipocyte-related clinical consequences (Hajer et al., 2008; 
Vázquez-Vela et al., 2008).  
 
The production of adipokines in obese adult is influenced by adipocyte hypertrophy 
(Skurk et al., 2007). However, in newborns higher proportion of fat tissue accumulate in the 
subcutaneous area and most of the internal fat is nonabdominal (Harrington et al., 2004), 
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(adopted from Goldstein et al., 2009) 
while the size of adipocytes is smaller than the adults (Escofet et al., 1996). Therefore, the 
differences in regional deposition and size of fat tissue might have accounted for the amount 
of adipokines in infants (Kotani et al., 2004). 
 
2.5.1 Adiponectin 
 
Adiponectin is a hormonal protein primarily expressed in adipocytes (Hu et al., 1996; Maeda 
et al., 1996). Firstly identified and described by Scherer et al. (1995) as Acrp30 (adipocyte 
complement-related protein of 30 kDa), adiponectin was reported in the literature by 
different names; AdipoQ (Hu et al., 1996), apM1 (Maeda et al., 1996) and GBP28 (Nakano 
et al., 1996). As the most abundantly expressed gene in adipocytes (Maeda et al., 1996; 
Matsuzawa et al., 2004), adiponectin is structurally composed of an N-terminal signal 
sequence at one end, followed by a collagen-like domain in the middle region and globular 
domain at C-terminal (Berg et al., 2002) (Figure 2.1).  
 
 
 
 
 
Figure 2.1 Structure of adiponectin  
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There are at least three forms of adiponectin in human plasma; a trimer, a hexamer, 
known as low-molecular-weight (LMW) oligomer, and a high-molecular-weight (HMW) 
multimer (Whitehead et al., 2006), which have variable ratios in individual human thus 
suggested that there are no correlation between total adiponectin and HMW adiponectin 
(Nakano et al., 2006). To activate the signalling molecules, there are two main adiponectin 
receptors involved, AdipoR1 and AdipoR2 (Yamauchi et al., 2003; Vasseur, 2006) as well as 
T-cadherin for hexameric and HMW adiponectin (Hug et al., 2004; Thundyil et al., 2012).  
 
Besides adipocytes, the expression of adiponectin and its receptors were also found 
in the bone-forming cells (osteoblasts) (Berner et al., 2004), endothelial cells and 
hepatocytes in liver (Kaser et al., 2005), myocardium (Fujioka et al., 2006), skeletal muscle 
(Yamauchi et al., 2003; Staiger et al., 2004), pancreas (Kharroubi et al., 2003), placenta 
(Caminos et al., 2005; Chen et al., 2006), pituitary gland and the brain (Psilopanagioti et al., 
2009) in mice and human. Due to androgens that reduce the expression of adiponectin 
(Nishizawa et al., 2002), men was shown to have a significantly lower level of total serum 
adiponectin as compared to women (Nakano et al., 2006).  
 
Adiponectin plays a central role in the modulation of lipid and glucose metabolism 
(Tsao et al., 2002; Yamauchi et al., 2002; Lin et al., 2013). When adiponectin binds with its 
receptor, the AMP-activated protein kinase (AMPK) phosphorylation is activated. The 
phosphorylation of AMPK inhibits acyl-CoA carboxylase (ACC), which subsequently 
reduces the production of malonyl-CoA thus enhances mitochondrial β-oxidation, a process 
of which energy balance is restored in human body. Other than regulating fatty acids 
oxidation, the activation of AMPK also promotes catabolic reactions- including glucose 
uptake, and inhibits anabolic reactions. Additionally, adiponectin also acts on the activation 
of peroxisome proliferator-activated receptor (PPARα) to increase energy metabolism in the 
body. (Lafontan and Viguerie, 2006). As the ‘starvation hormone’, adiponectin level 
increases in the state of caloric restriction/fasting/starvation to suppress energy expenditure 
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and stimulate energy intake, and the level of adiponectin decreases after feeding (Lee and 
Shao, 2014). Therefore, hypoadiponectinaemia and reduced expression of adiponectin 
receptors are associated with dysregulation of lipid and glucose metabolism, as well as 
development of obesity-linked insulin resistance (Yamauchi and Kadowaki, 2013).  
 
It was also revealed that adiponectin has anti-atherogenic properties (Matsuda et al., 
2002; Skrabal et al., 2011) and anti-inflammatory effects (Weyermann et al., 2006a; 
Villarreal-Molina and Antuna-Puente, 2012). Low level of adiponectin in blood was shown 
to relate with metabolic syndromes, diabetes mellitus and cardiovascular diseases (Behre, 
2007; Lara-Castro et al., 2007). In a study by Koh et al. (2009), adiponectin level was 
demonstrated to have significant negative association with the number of metabolic 
syndrome components, which suggested the increased risk of developing coronary heart 
disease and diabetes with lower level of adiponectin (Sattar et al., 2003). 
 
It is important to note that adiponectin level was inversely associated with adiposity 
(Gavrila et al., 2003; Fuglsang et al., 2006) and visceral fat accumulation in adult (Cnop et 
al., 2003) and children (Asayama et al., 2003), despite the fact that it is abundantly and 
exclusively produced in adipose tissue. The inverse relationship was also revealed between 
cord blood adiponectin and birth weight among LGA newborns (Mazaki-Tovi et al., 2005). 
On the contrary, cord blood adiponectin concentration was shown to have positive (Kotani et 
al., 2004) or no relationship with birth weight in full-term newborns from uncomplicated 
pregnancies (Lindsay et al., 2003; Kajantie et al., 2004). The increased size of adipocytes 
(hypertrophy) was related with the dysfunction of adipocytes, in which consequently resulted 
to the decrease in adiponectin secretion (Chevillotte et al., 2007).  
 
Given that hypertrophy and the inhibition of adipogenesis prevails in adiposity, 
hence it is possible to presume that hypertrophied adipocytes are may in part contribute to 
the distortion of adiponectin release as reported in previous studies on children and adults 
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with adiposity (Mathieu et al., 2010). Whereas disruption of adiponectin release among 
infants with adiposity might be attributable to the abnormally higher number of adipocytes 
(Hammami et al., 2001; Mazaki-Tovi et al., 2005), as opposed to the healthy infants with 
substantially higher number of smaller adipocytes in the subcutaneous region which enhance 
the secretion of adiponectin (Kotani et al., 2004). 
 
On the other hand, it was shown that the release of adiponectin by abdominal 
visceral adipocytes decreased with the rise of BMI (Motoshima et al., 2002), which might 
also explain the negative association of adiponectin with adiposity. A study among obese 
adolescents revealed that those with greater proportion of visceral fat and less subcutaneous 
fat had significantly lower concentration of adiponectin and were associated with other 
metabolic abnormalities, which proposed the higher risk of developing metabolic syndromes 
in later life (Taksali et al., 2008). While a study that investigated the difference of 
adiponectin level between two subgroups of obese men with high and low visceral fat 
accumulation found that those with high visceral fat level have significantly lower level of 
adiponectin, in fact they were in the lowest margin of the adiponectin level for all subjects 
(Côté et al., 2005). Multiple regression analysis from the study also reported that visceral fat 
accumulation was the only independent factor that explained the level of adiponectin.  
 
Furthermore, it was revealed that the concentration of adiponectin was significantly 
correlated with central adiposity (Park et al., 2004), and the results from multivariate 
analysis has also demonstrated that hypoadiponectinaemia was independently associated 
with abdominal visceral fat among type 2 diabetic Japanese men (Yatagai et al., 2003). The 
findings from these various studies postulated that visceral fat accumulation might account 
for most of the adiponectin secretion in the blood. Considering that the accumulation of 
visceral adipose tissue has influenced the changes in the release of adiponectin (Steffes et al., 
2004) and is closely related to metabolic derangements (Asayama et al., 2003; Lenchik et 
al., 2003), it is clearly evident that the reduced release of adiponectin is deleterious in the 
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(adopted from Matsuzawa, 2010) 
protection of human body from metabolic abnormalities and diseases. Taken together, a 
‘disease entity of hypoadiponectinaemia’ was proposed by Matsuzawa (2010) to explain the 
relationship of low level of adiponectin with various major diseases (Figure 2.2).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2  A disease entity of hypoadiponectinaemia  
  
Low level of adiponectin was related with adiposity (Comuzzie et al., 2001; Nemet 
et al., 2003), in which the significant reduction in body weight resulted to the increment of 
adiponectin level (Yang et al., 2001). Metabolic changes along with the change of weight 
might lead to the alteration of adiponectin levels (Abbasi et al., 2004a), given that the 
decline of insulin concentrations and increased of insulin sensitivity after weight loss 
(McLaughlin et al., 2001) were associated with a rise in the level of adiponectin (Maeda et 
al., 2001; Fasshauer et al., 2002).  
 
Despite that, there are several studies demonstrated that independent of adiposity, 
adiponectin level was strongly associated with insulin level (Möhlig et al., 2001; Joseph et 
al., 2002) and insulin resistance (Weyer et al., 2001; Tschritter et al., 2003). These findings 
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